164 related articles for article (PubMed ID: 18224333)
21. AMPD1 polymorphism and response to regadenoson.
Saab R; Zouk AN; Mastouri R; Skaar TC; Philips S; Kreutz RP
Pharmacogenomics; 2015 Nov; 16(16):1807-15. PubMed ID: 26554440
[TBL] [Abstract][Full Text] [Related]
22. A common variant of the AMPD1 gene predicts improved cardiovascular survival in patients with coronary artery disease.
Anderson JL; Habashi J; Carlquist JF; Muhlestein JB; Horne BD; Bair TL; Pearson RR; Hart N
J Am Coll Cardiol; 2000 Oct; 36(4):1248-52. PubMed ID: 11028479
[TBL] [Abstract][Full Text] [Related]
23. Effect of creatine supplementation on physical performance are related to the AMPD1 and PPARG genes polymorphisms in football players.
Lifanov D; Khadyeva MN; Rahmatullina LSh; Demenev SV; Ibragimov RR
Ross Fiziol Zh Im I M Sechenova; 2014 Jun; 100(6):767-76. PubMed ID: 25665401
[TBL] [Abstract][Full Text] [Related]
24. Effects of the 34C>T Variant of the AMPD1 Gene on Immune Function, Multi-Organ Dysfunction, and Mortality in Sepsis Patients.
Ramakers BP; Giamarellos-Bourboulis EJ; Tasioudis C; Coenen MJ; Kox M; Vermeulen SH; Groothuismink JM; van der Hoeven JG; Routsi C; Savva A; Prekates A; Diamantea F; Sinapidis D; Smits P; Toutouzas K; Riksen NP; Pickkers P;
Shock; 2015 Dec; 44(6):542-7. PubMed ID: 26529652
[TBL] [Abstract][Full Text] [Related]
25. AMPD1 gene mutations are associated with obesity and diabetes in Polish patients with cardiovascular diseases.
Safranow K; Suchy J; Jakubowska K; Olszewska M; Bińczak-Kuleta A; Kurzawski G; Rzeuski R; Czyżycka E; Łoniewska B; Kornacewicz-Jach Z; Ciechanowicz A; Chlubek D
J Appl Genet; 2011 Feb; 52(1):67-76. PubMed ID: 21108053
[TBL] [Abstract][Full Text] [Related]
26. Alterations in the blood velocity profile influence the blood flow response during muscle contractions and relaxations.
Osada T; Rådegran G
J Physiol Sci; 2006 Jun; 56(3):195-203. PubMed ID: 16839453
[TBL] [Abstract][Full Text] [Related]
27. AMPD1 (C34T) polymorphism and clinical outcomes in patients undergoing myocardial revascularization.
Andreassi MG; Botto N; Laghi-Pasini F; Manfredi S; Ghelarducci B; Farneti A; Solinas M; Biagini A; Picano E
Int J Cardiol; 2005 May; 101(2):191-5. PubMed ID: 15882662
[TBL] [Abstract][Full Text] [Related]
28. AMPD1 C34T mutation selectively affects AMP-deaminase activity in the human heart.
Kalsi KK; Yuen AH; Johnson PH; Birks EJ; Yacoub MH; Smolenski RT
Nucleosides Nucleotides Nucleic Acids; 2005; 24(4):287-8. PubMed ID: 16021918
[TBL] [Abstract][Full Text] [Related]
29. Alterations in the rheological flow profile in conduit femoral artery during rhythmic thigh muscle contractions in humans.
Osada T; Rådegran G
Jpn J Physiol; 2005 Feb; 55(1):19-28. PubMed ID: 15796786
[TBL] [Abstract][Full Text] [Related]
30. Variation in the gene for muscle-specific AMP deaminase is associated with insulin clearance, a highly heritable trait.
Goodarzi MO; Taylor KD; Guo X; Quiñones MJ; Cui J; Li X; Hang T; Yang H; Holmes E; Hsueh WA; Olefsky J; Rotter JI
Diabetes; 2005 Apr; 54(4):1222-7. PubMed ID: 15793265
[TBL] [Abstract][Full Text] [Related]
31. Myoadenylate deaminase deficiency does not affect muscle anaplerosis during exhaustive exercise in humans.
Tarnopolsky MA; Parise G; Gibala MJ; Graham TE; Rush JW
J Physiol; 2001 Jun; 533(Pt 3):881-9. PubMed ID: 11410643
[TBL] [Abstract][Full Text] [Related]
32. Molecular characterization and expression patterns of AMP deaminase1 (AMPD1) in porcine skeletal muscle.
Wang L; Mo X; Xu Y; Zuo B; Lei M; Li F; Jiang S; Deng C; Xiong Y
Comp Biochem Physiol B Biochem Mol Biol; 2008 Oct; 151(2):159-66. PubMed ID: 18638563
[TBL] [Abstract][Full Text] [Related]
33. Clinical significance and neuropathology of primary MADD in C34-T and G468-T mutations of the AMPD1 gene.
Fischer S; Drenckhahn C; Wolf C; Eschrich K; Kellermann S; Froster UG; Schober R
Clin Neuropathol; 2005; 24(2):77-85. PubMed ID: 15803807
[TBL] [Abstract][Full Text] [Related]
34. First missense mutations (R388W and R425H) of AMPD1 accompanied with myopathy found in a Japanese patient.
Morisaki H; Higuchi I; Abe M; Osame M; Morisaki T
Hum Mutat; 2000 Dec; 16(6):467-72. PubMed ID: 11102975
[TBL] [Abstract][Full Text] [Related]
35. Role of adenosine monophosphate deaminase-1 gene polymorphism in patients with congestive heart failure (influence on tumor necrosis factor-alpha level and outcome).
Gastmann A; Sigusch HH; Henke A; Reinhardt D; Surber R; Gastmann O; Figulla HR
Am J Cardiol; 2004 May; 93(10):1260-4. PubMed ID: 15135700
[TBL] [Abstract][Full Text] [Related]
36. Myoadenylate deaminase deficiency caused by alternative splicing due to a novel intronic mutation in the AMPD1 gene.
Isackson PJ; Bujnicki H; Harding CO; Vladutiu GD
Mol Genet Metab; 2005; 86(1-2):250-6. PubMed ID: 16040263
[TBL] [Abstract][Full Text] [Related]
37. AMPD1 genotypes and exercise capacity in McArdle patients.
Rubio JC; Pérez M; Maté-Muñoz JL; García-Consuegra I; Chamorro-Viña C; Fernández del Valle M; Andreu AL; Martín MA; Arenas J; Lucia A
Int J Sports Med; 2008 Apr; 29(4):331-5. PubMed ID: 17687759
[TBL] [Abstract][Full Text] [Related]
38. AMPD1 regulates mTORC1-p70 S6 kinase axis in the control of insulin sensitivity in skeletal muscle.
Tandelilin AA; Hirase T; Hudoyo AW; Cheng J; Toyama K; Morisaki H; Morisaki T
BMC Endocr Disord; 2015 Mar; 15():11. PubMed ID: 25887856
[TBL] [Abstract][Full Text] [Related]
39. Sex differences in leg vasodilation during graded knee extensor exercise in young adults.
Parker BA; Smithmyer SL; Pelberg JA; Mishkin AD; Herr MD; Proctor DN
J Appl Physiol (1985); 2007 Nov; 103(5):1583-91. PubMed ID: 17717115
[TBL] [Abstract][Full Text] [Related]
40. Near-infrared spectroscopy-derived total haemoglobin as an indicator of changes in muscle blood flow during exercise-induced hyperaemia.
Alvares TS; Oliveira GV; Soares R; Murias JM
J Sports Sci; 2020 Apr; 38(7):751-758. PubMed ID: 32106780
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
